Need help with Slope?
Email us and we'll be right with you.

Please include

Phone number
Study / Protocol

What We Do

Slope brings order, trust, and predictability to your clinical supply chain

Our Purpose

Make clinical trials boring.

Our Story

The concept for Slope sprang from a prior company founded by Rust and Michael Felix that forecast supply and demand for complex e-commerce supply chains. It was immensely unfulfilling work. Everything changed in late 2016 when the two brothers discovered that the supply chains running cutting-edge clinical trials were incredibly antiquated and chaotic. Fast forward to today, and Slope has become the leader in designing data-driven and patient-centric clinical supply chains for some of the most demanding studies on the planet.

Our Values

Slope has five core values that are near and dear to the hearts of everyone on our team. We are truly passionate about the work we do, and it shows.
1Patients are paramount.
2Better, stronger, faster.
3Driven by data.
4Job done, have fun.

Two Brothers, One Vision

Slope helps ClinOps teams make data-driven decisions that accelerate time-to-market for demanding studies.

Portrait of Rust Felix, co-founder and CEO of

Rust Felix

Co-founder / CEO
The older, taller Felix brother. Rust holds a Master's Degree in Mechanical Engineering with concentration in computational fluid dynamics. He is one of the few engineers who won't bore you deeply at a dinner party. Throughout his career Rust has used complex data sets to inform mathematical models that solve real problems.
Portrait of Michael Felix, co-founder and CTO of

Michael Felix

Co-founder / CTO
The younger, slightly shorter, (and some people would argue) more dashing Felix brother. Michael is an accomplished designer, developer, and educator with over 15 years of professional experience delivering human-centric software, systems, and services across industries ranging from eCommerce to clinical research.

Latest News

More Posts
Press Release
Oct 6
Slope Raises $20M in Series A Funding to Revolutionize Clinical Trial Operations through Automation
Slope today announced the closing of a $20 million Series A financing, led by global venture capital firm New Enterprise Associates, Inc. (NEA), to accelerate go-to-market efforts and further expand into decentralized and direct-to-patient clinical trials.
Read more
Apr 20
Do You Know Where Your Samples Are?
You probably don't, and it's probably been an issue in previous trials. Why is this such a problem? What is the potential impact? How do you fix it?
Read more
Dec 11
Don't Get Bit
It’s 4:45 PM on a Friday and a CRA gets a call. One of their Research Sites is scrambling. They have a patient coming in on Monday, and just discovered that all of the kits they need for a critical baseline visit are expired.
Read more

Watch us turn chaos into order.

Questions? Contact us to learn how Slope brings order, trust, and predictability to thousands of clinical trials around world.
Thank you
Your submission has been received.
There was a problem. Please try again.